SS
SCHWARTZ STEVEN D
Executive
OtherM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by SCHWARTZ STEVEN D, Executive. Insider active across 1 company, notably Bio-Rad Laboratories, INC.. Aggregated, 21 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €134k. History available since 2 September 2021. The latest transaction was disclosed on 6 September 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations21 total
3,455 shares0Bio-Rad A Common StockSEC:0000940805-25-000006:0
1,528 shares@ US$295.434.5% of flowBio-Rad A Common StockSEC:0000940805-25-000006:1
6,353 shares0Bio-Rad A Common StockSEC:0000940805-25-000004:0
3,005 shares0Bio-Rad A Common StockSEC:0001062993-24-016174:0
57 shares0Bio-Rad B Common StockSEC:0001062993-24-015818:0
57 shares0Bio-Rad B Common StockSEC:0001062993-24-015816:0
320 shares@ US$463.86100.0% of flowBio-Rad A Common StockSEC:0001062993-24-009134:0
49 shares0Bio-Rad B Common StockSEC:0001062993-23-022552:0
49 shares0Bio-Rad B Common StockSEC:0001062993-23-022114:0
35,000 shares@ US$119.8046.2% of flowBio-Rad B Common StockSEC:0001062993-23-020015:0
2,081 shares0Bio-Rad A Common StockSEC:0001062993-23-017146:0
42 shares0Bio-Rad B Common StockSEC:0001062993-22-023474:0
42 shares0Bio-Rad B Common StockSEC:0001062993-22-023089:0
1,805 shares0Bio-Rad A Common StockSEC:0001062993-22-019290:0
1,266 shares0Bio-Rad A Common StockSEC:0001062993-22-019202:0
39,250 shares@ US$107.3249.3% of flowBio-Rad B Common StockSEC:0001062993-22-018842:0
20 shares0Bio-Rad B Common StockSEC:0001062993-21-011444:0
20 shares0Bio-Rad B Common StockSEC:0001062993-21-011448:0
3,000 shares0Bio-Rad B Common StockSEC:0001062993-21-008418:0
2,319 shares0Bio-Rad A Common StockSEC:0001062993-21-008356:0
1,805 shares0Bio-Rad A Common StockSEC:0001062993-21-008256:0
About SCHWARTZ STEVEN D
Steven D. Schwartz is an Executive at BIO-RAD LABORATORIES, INC. He plays a key role in the strategic and operational direction of the company. His experience in the life sciences sector is beneficial for BIO-RAD in its innovation efforts.